FDG-PET/CT vs. Non-FDG Tracers in Less Explored Domains, An Issue of PET Clinics (The Clinics: Internal Medicine, nr. 17-3)

Editat de Sandip Basu, Rakesh Kumar, Abass Alavi
Notă GoodReads:
en Limba Engleză Hardback – 21 Jun 2022
In this issue, guest editors bring their considerable expertise to this important topic.

Provides in-depth reviews on the latest updates in the field, providing actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.
Citește tot Restrânge

Din seria The Clinics: Internal Medicine

Preț: 44306 lei

Preț vechi: 46638 lei

Puncte Express: 665

Preț estimativ în valută:
8565 8970$ 7421£

Carte disponibilă

Livrare economică 21 decembrie 22 - 04 ianuarie 23
Livrare express 06-10 decembrie pentru 5533 lei

Preluare comenzi: 021 569.72.76


ISBN-13: 9780323897181
ISBN-10: 0323897185
Pagini: 240
Dimensiuni: 263 x 186 x 20 mm
Greutate: 0.67 kg
Editura: Elsevier
Seria The Clinics: Internal Medicine


Facts and Fictions About [18F]FDG versus Other Tracers in Managing Patients with Brain Tumors: It Is Time to Rectify the Ongoing Misconceptions
An Appraisal and Update of Fluorodeoxyglucose and Non-Fluorodeoxyglucose-PET Tracers in Thyroid and Non-Thyroid Endocrine Neoplasms
18F-Fluorodeoxyglucose-PET-Computerized Tomography and non-Fluorodeoxyglucose PET-Computerized Tomography in Hepatobiliary and Pancreatic Malignancies
Molecular Imaging Assessment of Androgen Deprivation Therapy in Prostate Cancer
Molecular Imaging Assessment of Hormonally Sensitive Breast Cancer: An Appraisal of 2- [18F]-Fluoro-2-Deoxy-Glucose and Newer Non-2-[18F]-Fluoro-2-Deoxy-Glucose PET Tracers
18F-FDG Versus Non-FDG PET Tracers in Multiple Myeloma
Role of Molecular Imaging with PET/MR Imaging in the Diagnosis and Management of Brain Tumors
Fibroblast Activation Protein Inhibitor Theranostics
PET-CTBased Quantitative Parameters for Assessment of Treatment Response and Disease Activity in Cancer and Noncancerous Disorders
Positron Emission Tomography-Based Assessment of Cognitive Impairment and Dementias, Critical Role of Fluorodeoxyglucose in such Settings
Nonmalignant Thoracic Disorders: An Appraisal of Fluorodeoxyglucose and Non>fluorodeoxyglucose PET/Computed Tomography Applications
Fluorodeoxyglucose PET/Computed Tomography in Evaluation of Prosthetic Joints and Diabetic Foot: A Comparative Perspective with Other Functional Imaging Modalities
Utility of PET/Computed Tomography in Infection and Inflammation Imaging
Role of Fluorodeoxyglucose-PET in Interventional Radiology